Least squares mean differences ( @ % CI ) were statistically significant for vilazodone versus placebo on MADRS ( -@ -LSB- -@ to -@ -RSB- , P < @ ) and CGI-S ( -@ -LSB- -@ to -@ -RSB- , P < @ ) change from baseline ; statistically significant improvements versus placebo occurred at week @ and persisted for the study duration .